Dystrophin Genotype and Risk of Neuropsychiatric Disorders in Dystrophinopathies: A Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background: Dystrophinopathies are associated with neuropsychiatric disorders due to alterations in dystrophin/DMD expression. Objective: The objective was to estimate the association of developmental disorders, autism spectrum disorders (ASD), attention deficit hyperactivity disorder (ADHD), depression, anxiety disorders, and obsessive-compulsive disorder with the dystrophin/DMD genotype in population with dystrophinopathies. Methods: Systematic searches of Medline, Scopus, Web of Science, and Cochrane Library were performed from inception to September 2022. We included observational studies in the population with Becker or Duchenne muscular dystrophies (BMD, DMD) that estimated the prevalence of these disorders according to Dp140 and/or Dp71 genotype. Meta-analysis of the prevalence ratio (PR) of genotype comparisons was conducted for each disorder. Results: Ten studies were included in the systematic review. In BMD, Dp140+ vs. Dp140– and Dp71+ vs. Dp71– were associated with developmental disorders with a PR of 0.11 (0.04, 0.34) and 0.22 (0.07, 0.67), respectively. In DMD, Dp140+/Dp71+ vs. Dp140– /Dp71– had a PR of 0.40 (0.28, 0.57), and Dp71+ vs. Dp71– had a PR of 0.47 (0.36, 0.63) for ADHD. However, there was no association of genotype with ASD, only a trend was observed for Dp71+ vs. Dp71–, with a PR of 0.61 (0.35, 1.06). Moreover, the data showed no association of these isoforms with emotional-related disorders. Conclusions: In BMD, Dp140 and Dp71 could be associated with developmental disorders, while ADHD might be associated with the Dp71 genotype in DMD. Further research is needed regarding Dp140 and Dp71, especially in DMD for ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“obsessive-compulsive disorder (OCD; ∼7%) (Hendriksen and Vles, 2008; Darmahkasih et al., 2020; Pascual-Morena et al., 2023)”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Pascual-Morena et al., 2023
In the citing paper
“a higher chance of experiencing epileptic seizures (5%) (Hoogland et al., 2019; Pascual-Morena et al., 2023).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Pascual-Morena et al., 2023
In the citing paper
“autism spectrum disorder (ASD; ∼6%) (Hendriksen and Vles, 2008; Ricotti et al., 2016; Pascual-Morena et al., 2023)”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Pascual-Morena et al., 2023
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tufanaru, C., Munn, Z., Stephenson, M., & Aromataris, E. (2015) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000065 · Cited by 1,057 · cited 1×
“, BMD or DMD), a random effects meta-analysis was conducted [20, 21].”
BackgroundTripp, G., & Wickens, J. R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.026 · Cited by 492
Research works printed but not linked: 42
- Holland, 2014, Proteomics of the Dystrophin-glycoprotein Complex and Dystrophinopathy, Curr Protein Pept Sci [Internet], 14, 680, 10.2174/13892037113146660083 · doi:10.2174/13892037113146660083
- Waldrop, 2019, Update in Duchenne and Becker muscular dystrophy, Curr Opin Neurol [Internet], 32, 722, 10.1097/WCO.0000000000000739 · DOI
- Bushby, 1991, Prevalence and incidence of Becker muscular dystrophy, Lancet (London, England), 337, 1022, 10.1016/0140-6736(91)92671-N · DOI
- Mah, 2014, A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy, Neuromuscul Disord [Internet], 24, 482, 10.1016/j.nmd.2014.03.008 · DOI · Paper page
- Birnkrant, 2018, Diagnosis and management of Duchenne muscular dystrophy, part Diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management, Vol. 17, The Lancet Neurology. Lancet Publishing Group, 251
- Birnkrant, 2018, Diagnosis and management of Duchenne muscular dystrophy, part Respiratory, cardiac, bone health, and orthopaedic management, Lancet Neurol [Internet], 17, 347, 10.1016/S1474-4422(18)30025-5 · DOI · Paper page
- Pascual-Morena C , Cavero-Redondo C , Saz-Lara A , Sequí-Domínguez I , Lucerón-Lucas-Torres M , Martínez-Vizcaíno V . Genetic modifiers and phenotype of duchenne muscular dystrophy: A systematic review and meta-analysis. Pharmaceuticals (Basel) [Internet]. 2021[cited 2021 Nov 2];14(8). Available from: https://pubmed.ncbi.nlm.nih.gov/34451895/. · DOI
- Goemans, 2018, How glucocorticoids change life in Duchenne muscular dystrophy [Internet], The Lancet. Lancet Publishing Group, 391, 406
- Pascual-Morena, 2020, Restorative treatments of dystrophin expression in Duchenne muscular dystrophy: A systematic review, Ann Clin Transl Neurol [Internet], 7, acn3.51149
- Birnkrant, 2018, Diagnosis and management of Duchenne muscular dystrophy, part Primary care, emergency management, psychosocial care, and transitions of care across the lifespan, LANCET Neurol, 17, 445, 10.1016/S1474-4422(18)30026-7 · DOI · Paper page
- Sekiguchi, 2009, A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice, Brain, 132, 124, 10.1093/brain/awn253 · DOI · Paper page
- Doorenweerd, 2020, Combining genetics, neuropsychology and neuroimaging to improve understanding of brain involvement in Duchenne muscular dystrophy - a narrative review, Neuromuscul Disord [Internet], 30, 437, 10.1016/j.nmd.2020.05.001 · DOI
- Doorenweerd, 2017, Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy, Sci Rep, 7, 12575, 10.1038/s41598-017-12981-5 · DOI · Paper page
- Daoud, 2009, Role of mentalretardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions, PLoS One, 4, e6574, 10.1371/journal.pone.0006574 · DOI · Paper page
- Pascual-Morena, Prevalence of neuropsychiatric disorders in duchenne and becker musculardystrophies: A systematic review and meta-analysis, Arch Phys Med Rehabil, 2022
- Stroup, 2000, Meta-analysis of observational studies in epidemiology: A proposal for reporting, J Am Med Assoc [Internet], 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
- Higgins, 2008, Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series, 1, 10.1002/9780470712184 · DOI · Paper page
- Neumann, 2014, El sistema GRADE: Un cambio en la forma de evaluar la calidad de la evidencia y la fuerza de recomendaciones, Rev Med Chil [Internet], 142, 630, 10.4067/S0034-98872014000500012 · DOI
- DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Higgins, 2022, Quantifying heterogeneity in a meta-analysis, Stat Med [Internet], 21, 1539, 10.1002/sim.1186 · DOI · Paper page
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, Bmj [Internet], 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
- Lambert, 2020, Neurodevelopmental, behavioral, and emotional symptoms in Becker muscular dystrophy, Muscle Nerve, 61, 156, 10.1002/mus.26750 · DOI
- Mori-Yoshimura, 2018, Social involvement issues in patients with Becker muscular dystrophy: A questionnaire survey of subjects from a patient registry, Brain Dev, 40, 268, 10.1016/j.braindev.2017.11.004 · DOI
- Mori-Yoshimura, 2019, Psychiatric and neurodevelopmental aspects of Becker muscular dystrophy, Neuromuscul Disord, 29, 930, 10.1016/j.nmd.2019.09.006 · DOI
- Colombo, 2017, Assessing mental health in boys with Duchenne muscular dystrophy: Emotional, behavioural and neurodevelopmental profile in an Italian clinical sample, Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc, 21, 639, 10.1016/j.ejpn.2017.02.007 · DOI · Paper page
- Darmahkasih, 2020, Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy, Muscle and Nerve [Internet], 61, 466, 10.1002/mus.26803 · DOI · Paper page
- Pane, 2012, Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: Phenotype-genotype correlation, J Pediatr, 161, 705, 10.1016/j.jpeds.2012.03.020 · DOI · Paper page
- Ricotti, 2016, Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations, Dev Med Child Neurol, 58, 77, 10.1111/dmcn.12922 · DOI · Paper page
- Saito, 2022, Determining neurodevelopmental manifestations in Duchenne muscular dystrophy using a battery of brief tests, J Neurol Sci, 440, 120340, 10.1016/j.jns.2022.120340 · doi:10.1016/j.jns.2022.120340
- Thangarajh, 2019, Relationships between DMD mutations and neurodevelopment in dystrophinopathy, Neurology, 93, e1597, 10.1212/WNL.0000000000008363 · DOI
- Fujino, 2018, Autism spectrum disorders are prevalent among patients with dystrophinopathies, Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol, 39, 1279
- Graus-Porta, 2001, Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex, Neuron [Internet], 31, 367, 10.1016/S0896-6273(01)00374-9 · DOI · Paper page
- Ash, 2018, Neuropathophysiology of Duchenne muscular dystrophy: Involvement of the dystrophin isoform Dp71 in cell migration and proliferation, Neuromuscul Disord, 28, S13, 10.1016/S0960-8966(18)30328-6 · doi:10.1016/s0960-8966(18)30328-6
- Reiner, 2016, Regulation of neuronal migration, an emerging topic in autism spectrum disorders, J Neurochem [Internet], 136, 440, 10.1111/jnc.13403 · DOI · Paper page
- Jagadha, 1988, Brain morphology in Duchenne muscular dystrophy: A Golgi study, Pediatr Neurol, 4, 87, 10.1016/0887-8994(88)90047-1 · DOI · Paper page
- Grillner, 2002, Intrinsic membrane properties and synapticinputs regulating the firing activity of the dopamine neurons, BehavBrain Res [Internet], 130, 149
- Bruchhage, 2018, Cerebellar involvement in autism and ADHD, Handb Clin Neurol, 155, 61, 10.1016/B978-0-444-64189-2.00004-4 · DOI
- Vaillend, Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice, Hum Mol Genet [Internet], 26, 1041
- Domschke, 2011, Dysbindin (DTNBP1) - A role in psychotic depression?, J Psychiatr Res, 45, 588, 10.1016/j.jpsychires.2010.09.014 · DOI
- Latimer, 2017, Secondary conditions among males with duchenne or becker muscular dystrophy, J Child Neurol, 32, 663, 10.1177/0883073817701368 · DOI
- Brown, 2007, Effects of chronic prednisone therapy on mood and memory, J Affect Disord, 99, 279, 10.1016/j.jad.2006.09.004 · DOI
- Taylor, 2010, Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy, PLoS One, 5, e8803, 10.1371/journal.pone.0008803 · DOI · Paper page
Cited by
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Pascual-Morena, C., Cavero-Redondo, I., Martínez-Vizcaíno, V., Sequí-Domínguez, I., Fernández-Bravo-Rodrigo, J., & Jiménez-López, E.
- Affiliations
- Health and Social Research Center, Universidad deCastilla— La Mancha, Cuenca, Spain
- ORCID
- Venue
- Journal of Neuromuscular Diseases
- Publisher
- SAGE Publications
- Published
- 2023-03-07
- Volume
- 10
- Issue
- 2
- Pages
- 159-172
- ISSN
- 2214-3599
- 2214-3602
- Cited by
- 27
- References
- 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dystrophin Genotype and Risk of Neuropsychiatric Disorders in Dystrophinopathies: A Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.3233/jnd-221586
- The paper
- Pascual-Morena, C., Cavero-Redondo, I., Martínez-Vizcaíno, V., Sequí-Domínguez, I., Fernández-Bravo-Rodrigo, J., & Jiménez-López, E. (2023). Dystrophin Genotype and Risk of Neuropsychiatric Disorders in Dystrophinopathies: A Systematic Review and Meta-Analysis. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-221586
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.